Overview
Status
Active
Registry date
2019-10-22
Share capital
100,000.00 PLN
Registered address
ul. Krokwi 36/1, 03-114 Warszawa, Poland
Website
Electronic delivery address
AE:PL-74611-44485-TGTHI-20
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 390 days for 2020). All were audited by a statutory auditor.
- 202516/06/2026
- 202417/06/2025
- 202311/07/2024
- 202231/01/2024
- 202109/11/2022
- 202009/11/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.62kMedianUSD 267.96kAverageUSD 5.34m
Net profit
This companyUSD -40.92kMedianUSD 2.11kAverageUSD 362.44k
Operating costs
This companyUSD 42.92kMedianUSD 284.74kAverageUSD 4.73m
Assets
This companyUSD 131.35kMedianUSD 222.59kAverageUSD 4.07m
Industry
Authorized Representatives
Włodzimierz Józef Midak – Management Board Member
Wojciech Osiński – Management Board Member
Manner of representation
The joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to submit declarations of will and sign on behalf of the company.
Supervisory board
Danuta Midak – Supervisory Board Member
Dominik Midak – Supervisory Board Member
Tomasz Zbigniew Obrycki – Supervisory Board Member
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-04-01.
71 1020 4900 0000 8502 3647 9699
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nikalabsp. z o.o. | $2,614,050.94 | nikalab.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| Zojo. The Gorgeousness Companysp. z o.o. | $358,480.80 | zojoelixirs.com | ||
| VEGG Whitesp. z o.o. | $282,669.16 | vegg-white.com | ||
| Green Worldsp. z o.o. | $122,769.66 | en.world-food.com | ||
| Cannabis PolandS.A. | $55,015.30 | cannabispolandsa.com | ||
| Bulagosp. z o.o. | $44,002.93 | kavaha.pl | ||
| Proteinrisesp. z o.o. | $46,108.13 | proteinrise.com | ||
| Genezyxsp. z o.o. | $6,335.82 | genezyx.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-03-11 | PKD change (Removed: 10 codes; Added: 10 codes) | |
| 2019-10-22 | Entered in the register |
FAQ
The main business activity of Sativa-Med focuses on manufacture of other food products not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on October 22, 2019.
The headquarters is located at: ul. Krokwi 36, 03-114 Warszawa.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $2,620 in 2025, which is an increase of 242.9% compared to 2024.
No, the company recorded a net loss of $40,924 in 2025. For comparison, in 2024 the loss was $42,501, meaning the company reduced its loss by 3.9%.
The largest operating cost category falls under depreciation and amortization. This category amounted to $26,956 in 2025, representing 63% of all operating expenses.
Last updated: 2026-06-16